| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/22/2001 | WO2001019901A2 Process for making aqueous coated beadlets |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019528A1 Pore structures for reduced pressure aerosolization |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2001019407A2 Taxane prodrugs |
| 03/22/2001 | WO2001019406A2 Amphiphilic prodrugs |
| 03/22/2001 | WO2001019403A1 Liposomal mixture of local anesthetics and manufacturing method thereof |
| 03/22/2001 | WO2001019401A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 03/22/2001 | WO2001019400A2 Pharmaceutical composition in the form of a nucleic acid lipid complex, the production thereof and its use in gene therapy |
| 03/22/2001 | WO2001019391A1 Topical treatment of streptococcal infections |
| 03/22/2001 | WO2001019385A2 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | WO2001019383A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/22/2001 | WO2001019378A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 03/22/2001 | WO2001019372A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 03/22/2001 | WO2001019367A1 Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 03/22/2001 | WO2001019366A1 Topical treatment for prevention of ocular infections |
| 03/22/2001 | WO2001019363A1 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 03/22/2001 | WO2001019362A2 Formulations for treating or preventing mucositis |
| 03/22/2001 | WO2001019352A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 03/22/2001 | WO2001019351A1 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 03/22/2001 | WO2001019350A1 Controlled release formulation for administration of an anti-inflammatory naphthalene derivative |
| 03/22/2001 | WO2001019349A2 Extended release formulation of etodolac |
| 03/22/2001 | WO2001019348A1 Stabilization of enalapril maleate with maleic acid |
| 03/22/2001 | WO2001019346A1 Delayed release nabumetone formulation |
| 03/22/2001 | WO2001019345A1 Method to obtain microparticles |
| 03/22/2001 | WO2001019344A1 Method for the preparation of nasal powders by atomization using insoluble and absorbing excipients as nasal absorption promoters |
| 03/22/2001 | WO2001019342A2 Pharmaceutical formulation of fluticasone propionate |
| 03/22/2001 | WO2001019341A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | WO2001019340A1 Dispersion formulations containing lipase inhibitors |
| 03/22/2001 | WO2001019339A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | WO2001019337A2 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/22/2001 | WO2001019336A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 03/22/2001 | WO2001019335A2 Composition to be administered through mucous membrane |
| 03/22/2001 | WO2001019334A2 Pharmaceutical solutions of levosimendan |
| 03/22/2001 | WO2001019329A2 Polyoxyalkylene copolymers containing pourable liquid vehicles |
| 03/22/2001 | WO2001019325A1 Protective topical composition, products including the same, and methods |
| 03/22/2001 | WO2001019321A2 Methods for treating neuropathic pain using hetreoarylmethanesulfonamides |
| 03/22/2001 | WO2001019320A2 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | WO2001019305A1 Water absorbent keratin and gel formed therefrom |
| 03/22/2001 | WO2001019302A1 Disposable thermal body wrap |
| 03/22/2001 | WO2001019208A1 Directly compressable raw material for tablets |
| 03/22/2001 | WO2001019206A1 Process for manufacturing a pharmaceutical chewing gum |
| 03/22/2001 | WO2001019204A1 Breath freshening comestible product |
| 03/22/2001 | WO2001019191A1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 03/22/2001 | WO2001019183A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2001008661A3 Opioid sustained-released formulation |
| 03/22/2001 | WO2001008421A3 Tablet for programmed drug release |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2000069421A3 Transdermal therapeutic system (tts) containing tolterodine |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000030607A8 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a |
| 03/22/2001 | DE19944464A1 Verfahren zur Herstellung von Polyvinylpyrrolidon-lod in wässriger Lösung A process for preparing polyvinylpyrrolidone-iodine in aqueous solution |
| 03/22/2001 | DE19944402A1 Entwicklung einer effektiven Gentransfertechnik für das Einschleusen von Fremd-DNS in Spermienzellen Development of an effective gene transfer technology for the smuggling of foreign DNA in sperm cells |
| 03/22/2001 | DE19944137A1 O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin O / W emulsions with a content of one or more bioquinones and an elevated content of glycerol |
| 03/22/2001 | CA2637880A1 Process for manufacturing a pharmaceutical chewing gum |
| 03/22/2001 | CA2637770A1 Process for manufacturing a pharmaceutical chewing gum |
| 03/22/2001 | CA2386525A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 03/22/2001 | CA2385065A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | CA2384986A1 Transdermal administration of n-(2,5-disubstituted phenyl)-n'-(3-substituted phenyl)-n'-methyl guanidines |
| 03/22/2001 | CA2384881A1 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 03/22/2001 | CA2384876A1 Composition to be administered through mucous membrane |
| 03/22/2001 | CA2384726A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 03/22/2001 | CA2384646A1 Taxane prodrugs |
| 03/22/2001 | CA2384645A1 Amphiphilic prodrugs |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383405A1 Process for making aqueous coated beadlets |
| 03/22/2001 | CA2383038A1 Topical treatment of streptococcal infections |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2382008A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/22/2001 | CA2382005A1 Method to obtain microparticles |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/22/2001 | CA2350675A1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 03/21/2001 | EP1085096A2 Preparation of high trehalose content product |
| 03/21/2001 | EP1084726A2 Metered dose inhaler for fluticasone propionate |
| 03/21/2001 | EP1084708A1 A process of powder for bath from natural plants |
| 03/21/2001 | EP1084703A1 Controlled release preparations having multi-layer structure |
| 03/21/2001 | EP1084701A1 O/W-emulsion comprising one or several bioquinones and an elevated amount of glycerine |
| 03/21/2001 | EP1084693A1 $g(a)-HYDROXY FATTY ACID DERIVATIVES AND COMPOSITION FOR EXTERNAL USE CONTAINING THE SAME |
| 03/21/2001 | EP1084454A1 Free-form nanofabrication using multi-photon excitation |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1084172A1 Polyamino acid vesicles |
| 03/21/2001 | EP1084170A1 Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polyethylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers |
| 03/21/2001 | EP1083951A1 Methods of delivering aerosolized polynucleotides to the respiratory tract |
| 03/21/2001 | EP1083945A1 Encapsulation devices with strand, yarn or mesh core |
| 03/21/2001 | EP1083933A1 Device for the controlled release of active agents in the gastrointestinal tract with a prolonged pylorus passage |
| 03/21/2001 | EP1083932A1 Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
| 03/21/2001 | EP1083931A1 Stabilization of compositions containing ace inhibitors using magnesium oxide |
| 03/21/2001 | EP1083930A1 Insulin supplemented infant formula |
| 03/21/2001 | EP1083902A1 Novel galenic formulations of meloxicam for oral administration |
| 03/21/2001 | EP1083901A1 Efavirenz compressed tablet formulation |
| 03/21/2001 | EP1083900A2 Topical administration of oxazolidinones for transdermal delivery |
| 03/21/2001 | EP1083886A1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 03/21/2001 | EP1083885A1 Delavirdine tablet formulation |
| 03/21/2001 | EP1083884A1 Stabilised polyvinylpyrrolidone formulation |
| 03/21/2001 | EP1083883A1 Stabilizers for lyophilized vaccines |
| 03/21/2001 | EP1083882A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 03/21/2001 | EP1083881A2 Liposome composition and method for administering a quinolone |
| 03/21/2001 | EP1083880A1 Stable gel mixture in the form of a mixture of oleogel and aqueous gel |